,address1,address2,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Mr. Gary L. Crocker M.B.A., MBA', 'age': 70, 'title': 'Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman', 'yearBorn': 1952, 'fiscalYear': 2022, 'totalPay': 76000, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
1,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Dr. Ulrik B. Nielsen Ph.D.', 'age': 50, 'title': 'Co-Founder & Independent Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 72500, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
2,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Dr. Anthony J. Sinskey Ph.D., Sc.D.', 'age': 82, 'title': 'Co-Founder and Scientific Advisor', 'yearBorn': 1940, 'fiscalYear': 2010, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
3,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Geoffrey  Grande C.F.A.', 'title': 'Sr. Director of Communications', 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
4,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Ms. Ellen K. Forest', 'age': 58, 'title': 'Head of HR', 'yearBorn': 1964, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
5,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Dr. Daryl C. Drummond Ph.D.', 'age': 53, 'title': 'Head of Research', 'yearBorn': 1969, 'fiscalYear': 2017, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
6,One Broadway,14th Floor,Cambridge,MA,02142,United States,617 720 8606,https://www.merrimack.com,Biotechnology,Healthcare,"Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.","{'maxAge': 1, 'name': 'Mr. Timothy R. Surgenor', 'age': 62, 'title': 'Sec.', 'yearBorn': 1960, 'exercisedValue': 0, 'unexercisedValue': 0}",9,10,7,7,9,1693526400,1672444800,86400,2,12.41,12.35,12.1566,12.35,12.41,12.35,12.1566,12.35,1576195200,0.0,1.72372,-6.8764043,68187,68187,105320,41170,41170,12.19,12.23,1000,1100,175289040,3.0,13.66,12.0662,12.01565,0.0,0.0,USD,158038976,0.0,10185491,14321000,1074581,1084022,1690761600,1693440000,0.075,0.01208,0.52898,16.17,0.1031,1.329,9.209932,1672444800,1703980800,1688083200,-1596000,-0.11,-1.78,1271:1000,1567728000,NGM,EQUITY,MACK,MACK,"Merrimack Pharmaceuticals, Inc.","Merrimack Pharmaceuticals, Inc.",1333027800,America/New_York,EDT,-14400000,12.24,3.5,hold,18968000,1.324,0,46.151,47.304,-0.08454,-0.09776,-993250,-1473000,0.0,0.0,0.0,USD,
